6-12岁儿童的Lidcombe计划远程医疗治疗:第二阶段试验
Georgina Johnson1, Mark Onslow2, Brenda Carey2
1University of Melbourne, Department of Audiology & Speech Pathology, VIC, Australia.
Journal of fluency disorders
|April 13, 2024
概括
远程医疗Lidcombe计划对口的6至12岁儿童有希望,大约三分之一的孩子取得了显著的改善. 这种方法为减少口及其在这个年龄段的心理社会影响提供了一个可行的选择.
科学领域:
- 语音语言病理学 语言病理学
- 儿童心理学 儿童心理学
- 远程医疗的干预措施
背景情况:
- 6岁以上儿童口吃的临床研究是有限的.
- 随着年龄的增长,口吃的处理能力下降,心理风险增加.
- 语音语言病理学家需要有效的干预措施来治疗口吃的老年儿童.
研究的目的:
- 评估Lidcombe计划的远程医疗服务,用于自语的学龄儿童.
- 评估远程干预对儿童口吃的疗效.
主要方法:
- 一项II期试验,涉及来自不同国际地区的37名儿童 (6-12岁).
- 父母通过视频远程医疗接受了管理Lidcombe计划的培训.
- 测量结果包括的严重程度和6个月和12个月的心理社会功能.
主要成果:
- 6个月后,18.9%的人达到第二阶段的标准,67.6%的人显示部分反应,13.5%的人显示没有反应.
- 到了12个月,32.4%的孩子达到了第二阶段的标准.
- 在治疗后6个月和12个月,人们注意到了显著的心理社会改善.
结论:
- 通过远程医疗提供的Lidcombe计划可以显著减少约三分之一的6至12岁儿童的口吃.
- 建议对这一年龄组进行进一步的随机对照试验.
- 远程医疗Lidcombe计划是管理儿童口吃及其心理社会影响的实用临床选择.
更多相关视频
08:22Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
8.1K
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.7K
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
